Elliott B. Grossbard

2011

In 2011, Elliott B. Grossbard earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$292,005
Option Awards$322,082
Salary$486,675
Other$5,148
Total$1,105,910

Grossbard received $486.7K in salary, accounting for 44% of the total pay in 2011.

Grossbard also received $292K in non-equity incentive plan, $322.1K in option awards and $5.1K in other compensation.

Rankings

In 2011, Elliott B. Grossbard's compensation ranked 5,301st out of 10,747 executives tracked by ExecPay. In other words, Grossbard earned more than 50.7% of executives.

ClassificationRankingPercentile
All
5,301
out of 10,747
51st
Division
Manufacturing
1,922
out of 3,960
52nd
Major group
Chemicals And Allied Products
417
out of 1,038
60th
Industry group
Drugs
261
out of 786
67th
Industry
Pharmaceutical Preparations
205
out of 571
64th
Source: SEC filing on April 8, 2014.

Grossbard's colleagues

We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2011.

2011

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2011

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2011

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2011

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like